Darwin AG
Darwin AG operates in the healthcare industry. The company offers dietary supplements and cosmetics products. It also provides consulting and support services. The company was incorporated in 2021 and is based in Munich, Germany.
Market Cap & Net Worth: Darwin AG (7V0)
Darwin AG (XETRA:7V0) has a market capitalization of $98.54 Million (€96.00 Million) as of March 18, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #41541 globally and #6307 in its home market, demonstrating a -4.76% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Darwin AG's stock price €8.00 by its total outstanding shares 12000000 (12.00 Million).
Darwin AG Market Cap History: 2023 to 2026
Darwin AG's market capitalization history from 2023 to 2026. Data shows change from $419.32 Million to $98.54 Million (-45.80% CAGR).
Darwin AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Darwin AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
23.08x
Darwin AG's market cap is 23.08 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
10558.86x
Darwin AG's market cap is 10558.86 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $419.32 Million | $18.17 Million | $39.71K | 23.08x | 10558.86x |
Competitor Companies of 7V0 by Market Capitalization
Companies near Darwin AG in the global market cap rankings as of March 18, 2026.
Key companies related to Darwin AG by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Darwin AG Historical Marketcap From 2023 to 2026
Between 2023 and today, Darwin AG's market cap moved from $419.32 Million to $ 98.54 Million, with a yearly change of -45.80%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €98.54 Million | +3.90% |
| 2025 | €94.85 Million | -70.83% |
| 2024 | €325.19 Million | -22.45% |
| 2023 | €419.32 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Darwin AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $98.54 Million USD |
| MoneyControl | $98.54 Million USD |
| MarketWatch | $98.54 Million USD |
| marketcap.company | $98.54 Million USD |
| Reuters | $98.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.